KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 108 filers reported holding KURA ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 11.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,413,977 | +0.5% | 703,287 | +16.6% | 1.17% | +17.2% |
Q2 2023 | $6,382,776 | -13.5% | 603,287 | 0.0% | 1.00% | -19.1% |
Q1 2023 | $7,378,200 | +6.5% | 603,287 | +8.1% | 1.23% | -17.1% |
Q4 2022 | $6,928,342 | -35.8% | 558,287 | -29.3% | 1.49% | -0.7% |
Q3 2022 | $10,791,000 | +19.0% | 789,952 | +59.7% | 1.50% | +54.4% |
Q2 2022 | $9,066,000 | -8.8% | 494,595 | -20.0% | 0.97% | -31.0% |
Q1 2022 | $9,941,000 | -14.7% | 618,244 | -25.7% | 1.40% | +9.7% |
Q4 2021 | $11,651,000 | -21.1% | 832,238 | +5.5% | 1.28% | +3.2% |
Q3 2021 | $14,773,000 | -18.5% | 788,735 | -9.2% | 1.24% | +1.3% |
Q2 2021 | $18,116,000 | -10.7% | 868,886 | +21.1% | 1.22% | -21.3% |
Q1 2021 | $20,291,000 | +31.8% | 717,751 | +52.2% | 1.56% | +13.8% |
Q4 2020 | $15,399,000 | +39.8% | 471,494 | +31.2% | 1.37% | +26.3% |
Q3 2020 | $11,015,000 | +26.4% | 359,494 | -32.7% | 1.08% | +32.1% |
Q2 2020 | $8,712,000 | +36.0% | 534,494 | +51.9% | 0.82% | -7.2% |
Q2 2018 | $6,406,000 | +3.5% | 351,953 | +6.7% | 0.88% | -6.0% |
Q1 2018 | $6,188,000 | – | 330,000 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |